SLC10A2 and Chronic constipation: SLC10A2 inhibitors have previously been considered as a therapeutic candidate for type 2 diabetes48, but are now pursued as a treatment of chronic constipation due to the initially unwanted diarrhea and steatorrhea side-effects49.